Cardiac Arrest

FDA approves new indication for implantable cardioverter defibrillators

Published in Medical Letter on the CDC and FDA, August 18th, 2002

The U.S. Food and Drug Administration (FDA) has approved a new indication for Guidant Corp.'s implantable cardioverter defibrillators (ICDs) that expands the target population to include patients with a history of a heart attack and depressed heart function. The device is intended to prevent these patients from dying from a cardiac arrest.

The ICDs were previously approved for patients who had survived cardiac arrests and for patients who had undergone invasive electrical testing (done through a catheter from the groin to the heart) to determine if they were suitable candidates for an ICD. With the approval of this new indication, some patients may not be required to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2002-08-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry